Terms: = Breast cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
9617 results:
1. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
2. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
3. Anxiety Levels in Brazilian Women with Metastatic breast cancer Undergoing Palliative Chemotherapy: A Prospective Study.
Marcondes L; Silva LDS; Ribeiro CO; Oshiro NN; Nogueira LA; Guimaraes PRB; Kalinke LP
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1135-1141. PubMed ID: 38679972
[TBL] [Abstract] [Full Text] [Related]
4. Real-World Treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic breast cancer in a Canadian Setting Using AI-Extracted Data.
Moulson R; Feugère G; Moreira-Lucas TS; Dequen F; Weiss J; Smith J; Brezden-Masley C
Curr Oncol; 2024 Apr; 31(4):2172-2184. PubMed ID: 38668064
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic performance of contrast-enhanced mammography for suspicious findings in dense breasts: A systematic review and meta-analysis.
Lin ST; Li HJ; Li YZ; Chen QQ; Ye JY; Lin S; Cai SQ; Sun JG
Cancer Med; 2024 Apr; 13(8):e7128. PubMed ID: 38659408
[TBL] [Abstract] [Full Text] [Related]
6. Screening mammography performance according to breast density: a comparison between radiologists versus standalone intelligence detection.
Kwon MR; Chang Y; Ham SY; Cho Y; Kim EY; Kang J; Park EK; Kim KH; Kim M; Kim TS; Lee H; Kwon R; Lim GY; Choi HR; Choi J; Kook SH; Ryu S
Breast Cancer Res; 2024 Apr; 26(1):68. PubMed ID: 38649889
[TBL] [Abstract] [Full Text] [Related]
7. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
[No Abstract] [Full Text] [Related]
8. Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis.
Xia LY; Cao XC; Yu Y
World J Surg Oncol; 2024 Apr; 22(1):106. PubMed ID: 38643188
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
[TBL] [Abstract] [Full Text] [Related]
10. Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams.
Loap P; Giorgi M; Vu-Bezin J; Kirov K; Sampai JM; Prezado Y; Kirova Y
Cancer Radiother; 2024 Apr; 28(2):195-201. PubMed ID: 38599941
[TBL] [Abstract] [Full Text] [Related]
11. Investigating the detection of breast cancer with deep transfer learning using ResNet18 and ResNet34.
Subaar C; Addai FT; Addison ECK; Christos O; Adom J; Owusu-Mensah M; Appiah-Agyei N; Abbey S
Biomed Phys Eng Express; 2024 Apr; 10(3):. PubMed ID: 38599202
[TBL] [Abstract] [Full Text] [Related]
12. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.
Karihtala P; Leivonen SK; Puistola U; Urpilainen E; Jääskeläinen A; Leppä S; Jukkola A
Breast Cancer Res; 2024 Apr; 26(1):61. PubMed ID: 38594742
[TBL] [Abstract] [Full Text] [Related]
13. MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
van der Voort A; Louis FM; van Ramshorst MS; Kessels R; Mandjes IA; Kemper I; Agterof MJ; van der Steeg WA; Heijns JB; van Bekkum ML; Siemerink EJ; Kuijer PM; Scholten A; Wesseling J; Vrancken Peeters MTFD; Mann RM; Sonke GS;
Lancet Oncol; 2024 May; 25(5):603-613. PubMed ID: 38588682
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China.
Peng DM; Li J; Qiu JX; Zhao L
World J Surg Oncol; 2024 Apr; 22(1):88. PubMed ID: 38582875
[TBL] [Abstract] [Full Text] [Related]
15. Adiposity, Body Composition Measures, and breast cancer Risk in Korean Premenopausal Women.
Tran TXM; Chang Y; Choi HR; Kwon R; Lim GY; Kim EY; Ryu S; Park B
JAMA Netw Open; 2024 Apr; 7(4):e245423. PubMed ID: 38578637
[TBL] [Abstract] [Full Text] [Related]
16. 'Just Google it'-A scoping review of online mental health resources for survivors of breast cancer.
Tuckey N; Iasiello M; Corsini N; Koczwara B; Bareham M; Wellalagodage A; Wardill HR
Psychooncology; 2024 Apr; 33(4):e6337. PubMed ID: 38570325
[TBL] [Abstract] [Full Text] [Related]
17. Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy.
Lin D; Sturgeon KM; Muscat JE; Zhou S; Hobkirk AL; O'Brien KM; Sandler DP; Thompson CL
Breast Cancer; 2024 May; 31(3):519-528. PubMed ID: 38564089
[TBL] [Abstract] [Full Text] [Related]
18. Tumor-Infiltrating Lymphocytes in Triple-Negative breast cancer.
Leon-Ferre RA; Jonas SF; Salgado R; Loi S; de Jong V; Carter JM; Nielsen TO; Leung S; Riaz N; Chia S; Jules-Clément G; Curigliano G; Criscitiello C; Cockenpot V; Lambertini M; Suman VJ; Linderholm B; Martens JWM; van Deurzen CHM; Timmermans AM; Shimoi T; Yazaki S; Yoshida M; Kim SB; Lee HJ; Dieci MV; Bataillon G; Vincent-Salomon A; André F; Kok M; Linn SC; Goetz MP; Michiels S;
JAMA; 2024 Apr; 331(13):1135-1144. PubMed ID: 38563834
[TBL] [Abstract] [Full Text] [Related]
19. Alternative Lymphatic Drainage Pathways in the Trunk Following Oncologic Therapy.
Mehta M; Sarrami S; Moroni E; Fishman J; De La Cruz C
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S258-S261. PubMed ID: 38556685
[TBL] [Abstract] [Full Text] [Related]
20. Disparities in breast Reconstruction: An Analysis of Treatment Choices.
Eregha N; Villalvazo Y; De La Cruz C
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S223-S227. PubMed ID: 38556678
[TBL] [Abstract] [Full Text] [Related]
[Next]
